Massive flu drug trial aims to find best antivirals

NCT ID NCT05648448

Recruiting now Disease control Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

First seen Jan 12, 2026 · Last updated May 16, 2026 · Updated 18 times

Summary

This study tests how well different antiviral drugs clear the flu virus from the body. It involves 3000 adults aged 18-60 with early flu symptoms. Participants are randomly assigned to receive an antiviral or no treatment, and their viral levels are tracked daily for a week. The goal is to find which drugs work best to speed up recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Faculty of Tropical Medicine, Mahidol University
RECRUITING

Bangkok, 10400, Thailand

Contact Email: •••••@•••••
Laos-Oxford-Mahosot Wellcome Trust Research unit
RECRUITING

Vientiane, Laos

Contact Email: •••••@•••••
Sukraraj Tropical & Infectious Disease Hospital
RECRUITING

Kathmandu, Nepal

Contact Email: •••••@•••••
Universidade Federal de Minas Gerais
RECRUITING

Minas Gerais, Brazil

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

INFLUENZA INFLUENZA, HUMAN